PL368736A1 - Kompozycje do inhalacji zawierające tricykliczne 5,6-dihydro-9H-pirazolo(3,4-c)-1,2,4-triazolo(4,3-alfa) pirydyny - Google Patents

Kompozycje do inhalacji zawierające tricykliczne 5,6-dihydro-9H-pirazolo(3,4-c)-1,2,4-triazolo(4,3-alfa) pirydyny

Info

Publication number
PL368736A1
PL368736A1 PL02368736A PL36873602A PL368736A1 PL 368736 A1 PL368736 A1 PL 368736A1 PL 02368736 A PL02368736 A PL 02368736A PL 36873602 A PL36873602 A PL 36873602A PL 368736 A1 PL368736 A1 PL 368736A1
Authority
PL
Poland
Prior art keywords
triazolo
pyrazolo
dihydro
pyridine
alpha
Prior art date
Application number
PL02368736A
Other languages
English (en)
Inventor
Michael John Humphrey
Paul Robert Miller
Michael Trevor Shepherd
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of PL368736A1 publication Critical patent/PL368736A1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M13/00Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
PL02368736A 2001-09-12 2002-09-02 Kompozycje do inhalacji zawierające tricykliczne 5,6-dihydro-9H-pirazolo(3,4-c)-1,2,4-triazolo(4,3-alfa) pirydyny PL368736A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0122031.8A GB0122031D0 (en) 2001-09-12 2001-09-12 Use of pde4 inhibitors in a dry powder inhaler

Publications (1)

Publication Number Publication Date
PL368736A1 true PL368736A1 (pl) 2005-04-04

Family

ID=9921954

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02368736A PL368736A1 (pl) 2001-09-12 2002-09-02 Kompozycje do inhalacji zawierające tricykliczne 5,6-dihydro-9H-pirazolo(3,4-c)-1,2,4-triazolo(4,3-alfa) pirydyny

Country Status (35)

Country Link
US (3) US20030064031A1 (pl)
EP (1) EP1427414A1 (pl)
JP (1) JP2005505560A (pl)
KR (1) KR20040036940A (pl)
CN (1) CN1553801A (pl)
AP (2) AP2002002624A0 (pl)
AR (2) AR036473A1 (pl)
BG (1) BG108569A (pl)
BR (1) BR0212449A (pl)
CA (1) CA2457717A1 (pl)
CZ (1) CZ2004310A3 (pl)
EA (1) EA006742B1 (pl)
EC (1) ECSP045018A (pl)
EE (1) EE200400078A (pl)
GB (1) GB0122031D0 (pl)
HN (2) HN2002000253A (pl)
HR (1) HRP20040162A2 (pl)
HU (1) HUP0401890A3 (pl)
IL (1) IL160380A0 (pl)
IS (1) IS7151A (pl)
MA (1) MA27062A1 (pl)
MX (1) MXPA04002354A (pl)
NO (1) NO20041011L (pl)
NZ (1) NZ530929A (pl)
OA (1) OA12660A (pl)
PA (2) PA8554701A1 (pl)
PE (2) PE20030443A1 (pl)
PL (1) PL368736A1 (pl)
PY (2) PY0221504A (pl)
SK (1) SK1272004A3 (pl)
SV (2) SV2004001227A (pl)
TN (1) TNSN04040A1 (pl)
TW (1) TW200602054A (pl)
WO (2) WO2003022279A1 (pl)
ZA (1) ZA200401002B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7931022B2 (en) 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
MXPA05007156A (es) * 2002-12-31 2005-09-21 Nektar Therapeutics Formulacion farmaceuticas aerosolizable para terapia para infecciones fungicas.
GB0315889D0 (en) 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
US20060009435A1 (en) * 2004-06-23 2006-01-12 Joseph Kaspi Synthesis and powder preparation of fluticasone propionate
CA2623882A1 (en) * 2005-09-28 2007-04-05 Merck Frosst Canada Ltd. Aerosol powder formulation comprising sieved lactose
GB0801876D0 (en) * 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
US8834931B2 (en) 2009-12-25 2014-09-16 Mahmut Bilgic Dry powder formulation containing tiotropium for inhalation
TR200909788A2 (tr) * 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu
CA2900302C (en) 2013-02-19 2018-07-03 Pfizer Inc. Azabenzimidazole compounds as inhibitors of pde4 isozymes for the treatment of cns and other disorders
KR20150076005A (ko) 2013-12-26 2015-07-06 삼성디스플레이 주식회사 액정 표시 장치
WO2016012896A1 (en) 2014-07-24 2016-01-28 Pfizer Inc. Pyrazolopyrimidine compounds
CR20170035A (es) 2014-08-06 2017-04-28 Pfizer Compuestos de imidazopiridazina
HUE055527T2 (hu) * 2014-09-15 2021-12-28 Verona Pharma Plc RPL554-t tartalmazó folyékony inhalációs készítmény

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69525978T2 (de) * 1995-06-06 2002-12-19 Pfizer Trizyclische 5,6-dihydro-9h-pyrazolo(3,4-c)-1,2,4-triazolo(4,3-alpha)pyridine
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
DE19835346A1 (de) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren

Also Published As

Publication number Publication date
BR0212449A (pt) 2004-08-17
SK1272004A3 (sk) 2005-03-04
TW200602054A (en) 2006-01-16
OA12660A (en) 2006-06-19
CA2457717A1 (en) 2003-03-20
HRP20040162A2 (en) 2004-08-31
SV2004001226A (es) 2004-02-24
EA006742B1 (ru) 2006-04-28
ECSP045018A (es) 2004-04-28
ZA200401002B (en) 2005-02-07
EE200400078A (et) 2004-06-15
BG108569A (bg) 2005-02-28
EP1427414A1 (en) 2004-06-16
IS7151A (is) 2004-02-13
PA8554601A1 (es) 2003-09-17
MA27062A1 (fr) 2004-12-20
HUP0401890A3 (en) 2008-03-28
AR036474A1 (es) 2004-09-08
AP2002002623A0 (en) 2002-09-30
AR036473A1 (es) 2004-09-08
TNSN04040A1 (fr) 2006-06-01
EA200400301A1 (ru) 2004-06-24
NZ530929A (en) 2006-08-31
AP2002002624A0 (en) 2002-09-30
WO2003022279A1 (en) 2003-03-20
HN2002000253A (es) 2003-04-07
GB0122031D0 (en) 2001-10-31
US20030064031A1 (en) 2003-04-03
HUP0401890A2 (hu) 2004-12-28
NO20041011L (no) 2004-03-10
PE20030443A1 (es) 2003-05-17
CZ2004310A3 (cs) 2005-02-16
PY0221504A (es) 2004-04-01
WO2003022275A1 (en) 2003-03-20
US20050232871A1 (en) 2005-10-20
PE20030509A1 (es) 2003-06-23
CN1553801A (zh) 2004-12-08
US20030064034A1 (en) 2003-04-03
HN2002000254A (es) 2003-04-07
PA8554701A1 (es) 2003-09-17
IL160380A0 (en) 2004-07-25
JP2005505560A (ja) 2005-02-24
MXPA04002354A (es) 2004-06-29
SV2004001227A (es) 2004-02-24
KR20040036940A (ko) 2004-05-03
PY0221503A (es) 2004-04-01

Similar Documents

Publication Publication Date Title
IL152869A0 (en) Substituted triazolopyrimidines as anticancer agents
ZA200306886B (en) Pyrazolopyrimidines as therapeutic agents.
IL157640A0 (en) Pyrazolopyrimidines as therapeutic agents
ATE380031T1 (de) Pyrrolo 2,3-d pyrimidinderivate enthaltende zusammensetzungen
HUP0500109A3 (en) Synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
IL156567A0 (en) Triazolopyridines as anti-inflammatory agents
PL368736A1 (pl) Kompozycje do inhalacji zawierające tricykliczne 5,6-dihydro-9H-pirazolo(3,4-c)-1,2,4-triazolo(4,3-alfa) pirydyny
DE60009346D1 (de) Buprenorphin enthaltende analgetische zusammensetzungen
PL369404A1 (pl) Wytrzymałe na uderzenie kompozycje poliolefinowe
HUP0400648A3 (en) Compositions for antitumour treatment containing ecteinascidin 743
DE69525978D1 (de) Trizyclische 5,6-dihydro-9h-pyrazolo(3,4-c)-1,2,4-triazolo(4,3-alpha)pyridine
MXPA03008965A (es) Uso de compuestos de imidazo [1,2-a]-piridinas sustituidas como medicamentos.
AU2001271876A1 (en) Azepino(4,5-b)pyrano(3,2-e)indoles
GB0111901D0 (en) Jungle gym
ZA200602387B (en) 6-[(Substituted)phenyl]triazolopyrimidines as anticancer agents
ATE274899T1 (de) Im mund zerfallende zusammensetzung mit mirtazapin
GB0219513D0 (en) Inhalation compositions including coarse carrier
GB0000187D0 (en) Chemical compositions II
IL175724A0 (en) Tricyclic imidazopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0303486A3 (en) Compositions containing 3,7-diazabicyclo [3,3,1] compounds as anti-arrythmic compounds agents
MXPA03008894A (es) Uso de compuestos de imidazo[1,2-a]-piridin-3-il-amidas e imidazo [1,2-a]-piridin-3-il-aminas sustituidas como medicamentos.
EP1415983A4 (en) 5-AMIDINO-N- (2-AMINOPHENETHYL) -N-HYDROXYBENZENSULFONAMIDE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING SAME, AND INTERMEDIATE USING SAME
AU2002334256A1 (en) Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines and a tiotropium salt
GB2395653B (en) Sportswear for team players
SE0004098D0 (sv) Novel compounds

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)